GPT-5.4 is also more reliable, producing 18% fewer errors and 33% fewer false claims than GPT-5.2, according to OpenAI.

Detailed price information for Cannabix Technologies Inc (BLO-CN) from The Globe and Mail including charting and trades.

The PHARMIGA consortium has been awarded a multi-million euro investment to build a national research network focused on developing medicines based on IgA antibodies.

Introduction Forced migrants (i.e., asylum seekers and refugees) experience greater mental health disparities and inequities in care. Mental health services and systems lack clear policy on integrated ...

This article explores multiplexing applications in biopharma and highlights key assay development factors to consider.

Spec-Driven Development sets written specs before AI coding; a 4-step flow links requirements, design docs, tests, and QA.

Many biological functions are regulated by the switching on and off of mechanisms triggered by the matching of a keyhole ...

Biobased testing reveals the percentage of biobased versus fossil carbon content in a given sample.Biobased carbon testing helps manufacturers develop materials that mee ...

Lightbridge (NASDAQ:LTBR) used its fiscal 2025 business update and conference call to highlight a series of technical ...

So long as it doesn't ratify the Comprehensive Nuclear Test Ban Treaty, the United States won't be able to seek short-notice, on-site inspections to deter and detect possible Chinese and Russian ...

Background Congenital anomalies are among the common health problems faced by children in low- and middle-income countries, ...

The use of acidic MPAs (pH 2–4) is the default in pharmaceutical testing because they suppress silanol ionization (from Si-OH to Si-O -) and improve peak shape for basic drugs. However, highly ...